Brain aneurysm blood flow software tested for predicting stent success

NCT ID NCT03663257

Completed Knowledge-focused Sponsor: Philips Clinical & Medical Affairs Global Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a software tool called AneurysmFlow that measures blood flow in brain aneurysms. The goal was to see if it can predict whether an aneurysm will fully close 12 months after a stent is placed. 132 adults with unruptured brain aneurysms participated. The tool is already approved for use, and this study aims to confirm its predictive value.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AneurysmFlow software (a device that analyzes blood flow images from angiograms)
What this could lead to: If successful, this tool could help doctors predict which brain aneurysms will close after stent placement, potentially guiding treatment decisions.
What could go wrong: This is an observational study, not a treatment trial. The tool is already approved, but its real-world benefit for patients is still being evaluated. Results may not apply to all aneurysm types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm brain aneurysm intracranial berry aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACRANIAL ANEURYSM

Contacts and locations

Show contact details

Locations

Baptist Health

Jacksonville, Florida, 32207, United States
ENERI

Buenos Aires, C1428 CABA, Argentina
Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada
UMass Medical Center

Worcester, Massachusetts, 01655, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.